Cargando…
Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment
Non-small cell lung cancer (NSCLC) is one of the most common malignancies in the world. Although extensive studies showed that luteolin exhibited antitumor effects against NSCLC, the mechanism has not been fully established. In the present study, we found that luteolin significantly reduced the expr...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399355/ https://www.ncbi.nlm.nih.gov/pubmed/30833546 http://dx.doi.org/10.1038/s41419-019-1447-y |